TQD3606

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQD3606, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency [Phase 1]

See pricing